Hepatitis C drugs Market Trends, Growth And Regional Outlook and Forecast 2022-2030
Overview:
Hepatitis C drugs market was valued USD 18700 million and expected to reach USD 281.55 million by the end of forecasting period reflecting a sluggish CAGR of 1.17% by 2030.
The hepatitis C drug market trends is getting bolstered by the increasing disease prevalence, effective use of government subsidy and reimbursement schemes, increasing screening opportunities, drug abuse in several...
0 Kommentare
0 Anteile